April 9, 2023 Comments Off on New patent expiration for Astrazeneca Ab drug BYDUREON BCISE Posted in: Uncategorized
Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are fifteen…
The post New patent expiration for Astrazeneca Ab drug BYDUREON BCIS…
April 9, 2023 Comments Off on New patent expiration for Astrazeneca Ab drug BYDUREON Posted in: Uncategorized
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are twenty-three patents…
The post New patent expiration for Astrazeneca Ab drug BYDUREON ap…